Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia

被引:19
作者
Ghoshal Gupta, Ampa [1 ]
Baumann, Heinz [2 ]
Wetzler, Meir [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA
关键词
signal transducer and activator of transcription 3; hypermethylation; acute myeloid leukemia;
D O I
10.1016/j.leukres.2007.11.035
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have demonstrated that constitutive signal transducer and activator of transcription (STAT) 3 activity, observed in approximately 50% of acute myeloid leukemia (AML) cases, is associated with adverse treatment outcome. Constitutive STAT3 activation may result from the expression of oncogenic protein tyrosine kinases or from autocrine stimulation by hematopoietic growth factors. These causes are generally neither necessary nor sufficient for leukemogenesis; additional transforming events or growth stimulatory processes are needed. Here we review the literature addressing epigenetic regulation as a mechanism controlling STAT3 signaling in AML. A better understanding of mechanisms of dysregulation of STAT signaling pathways may serve as a basis for designing novel therapeutic strategies that target these pathways in leukemia cells. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1005 / 1014
页数:10
相关论文
共 90 条
[61]   RETRACTED: Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis (Retracted article. See vol. 31, pg. 979, 2013) [J].
Roman-Gomez, J ;
Jimenez-Velasco, A ;
Agirre, X ;
Prosper, F ;
Heiniger, A ;
Torres, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :7043-7049
[62]  
Roman-Gomez J, 2004, HAEMATOLOGICA, V89, P42
[63]   The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer [J].
Rycyzyn, MA ;
Clevenger, CV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6790-6795
[64]   Constitutive expression of SOCS3 confers resistance to IFN-α in chronic myelogenous leukemia cells [J].
Sakai, I ;
Takeuchi, K ;
Yamauchi, H ;
Narumi, H ;
Fujita, S .
BLOOD, 2002, 100 (08) :2926-2931
[65]   Evaluation of a 7-day continuous intravenous infusion of decitabine: Inhibition of promoter-specific and global genomic DNA methylation [J].
Samlowski, WE ;
Leachman, SA ;
Wade, M ;
Cassidy, P ;
Porter-Gill, P ;
Busby, L ;
Wheeler, R ;
Boucher, K ;
Fitzpatrick, F ;
Jones, DA ;
Karpf, AR .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (17) :3897-3905
[66]   Differential express-ion of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma [J].
Sanchez-Ceja, S. G. ;
Reyes-Maldonado, E. ;
Vázquez-Manríquez, M. E. ;
López-Luna, J. J. ;
Belmont, A. ;
Gutierrez-Castellanos, S. .
LUNG CANCER, 2006, 54 (02) :163-168
[67]   Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura [J].
Schrump, David S. ;
Fischette, Maria R. ;
Nguyen, Dao M. ;
Zhao, Ming ;
Li, Xinmin ;
Kunst, Tricia F. ;
Hancox, Ana ;
Hong, Julie A. ;
Chen, G. Aaron ;
Pishchik, Vitaliy ;
Figg, William D. ;
Murgo, Anthony J. ;
Steinberg, Seth M. .
CLINICAL CANCER RESEARCH, 2006, 12 (19) :5777-5785
[68]   Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia:: possible inadequacy of a negative feedback mechanism [J].
Schultheis, B ;
Carapeti-Marootian, M ;
Hochhaus, A ;
Weisser, A ;
Goldman, JM ;
Melo, JV .
BLOOD, 2002, 99 (05) :1766-1775
[69]   STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells [J].
Sillaber, C ;
Gesbert, F ;
Frank, DA ;
Sattler, M ;
Griffin, JD .
BLOOD, 2000, 95 (06) :2118-2125
[70]   Activated signal transducer and activator of transcription (STAT) 3: Localization in focal adhesions and function in ovarian cancer cell motility [J].
Silver, DL ;
Naora, H ;
Liu, JS ;
Cheng, WJ ;
Montell, DJ .
CANCER RESEARCH, 2004, 64 (10) :3550-3558